Apigenin, a Partial Antagonist of the Estrogen Receptor (ER), Inhibits ER-Positive Breast Cancer Cell Proliferation through Akt/FOXM1 Signaling

Approximately 80% of breast cancer (BC) cases express the estrogen receptor (ER), and 30–40% of these cases acquire resistance to endocrine therapies over time. Hyperactivation of Akt is one of the mechanisms by which endocrine resistance is acquired. Apigenin (Api), a flavone found in several plant...

Descripción completa

Detalles Bibliográficos
Autores principales: Pham, Thu Ha, Page, Yann Le, Percevault, Frédéric, Ferrière, François, Flouriot, Gilles, Pakdel, Farzad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7796491/
https://www.ncbi.nlm.nih.gov/pubmed/33466512
http://dx.doi.org/10.3390/ijms22010470

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7796491/
https://www.ncbi.nlm.nih.gov/pubmed/33466512
http://dx.doi.org/10.3390/ijms22010470

Ejemplares similares